Pages that link to "Q42716061"

The following pages link to Lipoic acid effects on established atherosclerosis (Q42716061):

Displaying 26 items.

• The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress (Q26822734) (← links)
• Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases (Q34012029) (← links)
• Lipoic acid - biological activity and therapeutic potential (Q34029023) (← links)
• Alpha-lipoic acid activates eNOS through activation of PI3-kinase/Akt signaling pathway (Q35091422) (← links)
• Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese Zucker rats (Q35111400) (← links)
• A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes (Q35711283) (← links)
• Alpha-Lipoic Acid and Antioxidant Diet Help to Improve Endothelial Dysfunction in Adolescents with Type 1 Diabetes: A Pilot Trial (Q35773388) (← links)
• Lipoicmethylenedioxyphenol Reduces Experimental Atherosclerosis through Activation of Nrf2 Signaling (Q35918474) (← links)
• Complementary Cholesterol-Lowering Response of a Phytosterol/α-Lipoic Acid Combination in Obese Zucker Rats (Q35931637) (← links)
• Influence of antioxidant complex on the adhesion of leukocytes in chronic venous insufficiency of lower limbs in rats (Q36470192) (← links)
• Practical strategies for modulating foam cell formation and behavior (Q38261037) (← links)
• Influence of alpha-lipoic acid on nicotine-induced lung and liver damage in experimental rats. (Q38972178) (← links)
• Potential Intervention of α- Lipoic Acid and Carnitine on Insulin Sensitivity and Anti-Inflammatory Cytokines Levels in Fructose-Fed Rats, a Model of Metabolic Syndrome (Q39521057) (← links)
• Increasing the Biological Stability Profile of a New Chemical Entity, UPEI-104, and Potential Use as a Neuroprotectant Against Reperfusion-Injury (Q41333808) (← links)
• Reduction of conjunctival fibrosis after trabeculectomy using topical α-lipoic acid in rabbit eyes (Q42174211) (← links)
• α-Lipoic acid reduced weight gain and improved the lipid profile in rats fed with high fat diet (Q42235220) (← links)
• Redox homeostasis of albumin in relation to alpha-lipoic acid and dihydrolipoic acid. (Q42412100) (← links)
• Lipoic acid attenuates the expression of adhesion molecules by increasing endothelial nitric-oxide synthase activity (Q44280664) (← links)
• Insights on Localized and Systemic Delivery of Redox-Based Therapeutics. (Q52720174) (← links)
• Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study. (Q53014867) (← links)
• Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway. (Q53389036) (← links)
• The Immunomodulatory Effect of Alpha-Lipoic Acid in Autoimmune Diseases (Q64068664) (← links)
• Cellular mechanisms by which lipoic acid confers protection during the early stages of cerebral ischemia: A possible role for calcium (Q83032667) (← links)
• THE EFFECT OF SHORT TERM ALPHA LIPOIC ACID ADMINISTRATION ON ADIPONECTIN AND BODY WEIGHT IN TYPE 2 DIABETES MELLITUS PATIENTS (Q92432103) (← links)
• Insights on the Use of α-Lipoic Acid for Therapeutic Purposes (Q92570238) (← links)
• Alpha-Lipoic Acid as a Means of Influence on Systemic Inflammation in Type 2 Diabetes Mellitus Patients with Prior Myocardial Infarction (Q93271520) (← links)